United Kingdom· GB-APID-28392311000001106
Velphoro 500mg chewable tablets
A sucroferric oxyhydroxide product containing sucroferric oxyhydroxide, registered in United Kingdom by Vifor Fresenius Medical Care Renal Pharma UK Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sucroferric oxyhydroxide is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AE05 (sucroferric oxyhydroxide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Sucroferric oxyhydroxide · ATC V03AE05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of sucroferric oxyhydroxide costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sucroferric oxyhydroxide · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.80
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sucroferric oxyhydroxide
- Manufacturer
- Vifor Fresenius Medical Care Renal Pharma UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- V03AE05
- ATC class
- Sucroferric oxyhydroxide
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7640114723773
- gtin07640166810148
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sucroferric oxyhydroxide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVelphoro 500 mg comprimidos masticablesVifor Fresenius Medical Care Renal Pharma France
- FranceVELPHORO 500 mg, comprimé à croquerVIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
- BelgiumVelphoro 500 mgVifor Fresenius Medical Care Renal Pharma France
- NorwayVelphoroVifor Fresenius Medical Care Renal Pharma France (1)
- SwedenVelphoro 500 mg TuggtablettVifor Fresenius Medical Care Renal Pharma France
- United StatesVelphoroFresenius Medical Care Renal Therapies Group, LLC
- IcelandVelphoroVifor Fresenius Medical Care Renal Pharma France*
- Japanスクロオキシ水酸化鉄キッセイ薬品工業
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Velphoro
- Liechtenstein · Velphoro
- Norway · Velphoro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/717fe0a6-fb95-4277-b83e-fdabc05950a0 GET /v1/drugs/717fe0a6-fb95-4277-b83e-fdabc05950a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "28392311000001106",
"desc": "Velphoro 500mg chewable tablets (Vifor Fresenius Medical Care Renal Pharma UK Ltd)",
"form": "Chewable tablet",
"vpid": "28423311000001102",
"source": "dmd",
"vtm_id": "1285050003",
"strength": "500 mg",
"substance": "Sucroferric oxyhydroxide",
"ingredient": "Sucroferric oxyhydroxide",
"supplier_code": "31307311000001104"
}See everything about sucroferric oxyhydroxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.